Literature DB >> 19022016

Video-assisted thoracoscopic left cardiac sympathetic denervation: a reliable minimally invasive approach for congenital long-QT syndrome.

Jianfeng Li1, Yanguo Liu, Fan Yang, Guanchao Jiang, Cuilan Li, Dayi Hu, Jun Wang.   

Abstract

BACKGROUND: The purpose of this study was to assess the feasibility and long-term effect of video-assisted thoracoscopic left cardiac sympathetic denervation for congenital long-QT syndrome.
METHODS: From December 2002 to May 2007, 11 patients who could not tolerate or who were refractory to beta-blocker therapy received video-assisted thoracoscopic left cardiac sympathetic denervation. Under general anesthesia, the pleural cavity was entered through three 1.5-cm incisions in the left subaxillary area. The left thoracic sympathetic chain was identified, and the lower one third of the left stellate ganglion, together with T(2) to T(5) sympathetic chain, was resected.
RESULTS: The mean operative time was 40.9 +/- 7.7 minutes. Blood loss was minimal. The mean postoperative stay was 6 +/- 1.4 days. There were no major perioperative complications apart from mild ptosis of the left upper eyelid in 1 patient who subsequently recovered shortly after the procedure. The mean follow-up time was 37.0 +/- 26.3 months. Seven of the patients are totally free of cardiac events and report good quality of life. One patient experienced decreased syncopal events from 5 or 6 times per year to 2 or 3 times per year. One patient still experiences syncopal events 3 to 4 times a year, but with shortened duration to several seconds. One patient reports syncope 10 times per year. Only 1 patient died, early in the second year after surgery. In conclusion, the overall efficacy rate (that is, reduction in syncopal episodes) is 81.8% (9 of 11) and the mortality rate, 9.1% (1 of 11).
CONCLUSIONS: Video-assisted thoracoscopic left cardiac sympathetic denervation is a simple and minimally invasive technique that results in good long-term benefits in patients with congenital long-QT syndromes.

Entities:  

Mesh:

Year:  2008        PMID: 19022016     DOI: 10.1016/j.athoracsur.2008.07.100

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation.

Authors:  Tara Bourke; Marmar Vaseghi; Yoav Michowitz; Vineet Sankhla; Mandar Shah; Nalla Swapna; Noel G Boyle; Aman Mahajan; Calambur Narasimhan; Yash Lokhandwala; Kalyanam Shivkumar
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

3.  Cardiac spinal deafferentation reduces the susceptibility to sustained ventricular tachycardia in conscious rats.

Authors:  Heidi L Lujan; Sandhya Krishnan; Stephen E Dicarlo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

4.  Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review.

Authors:  Lingjin Meng; Chi-Hong Tseng; Kalyanam Shivkumar; Olujimi Ajijola
Journal:  JACC Clin Electrophysiol       Date:  2017-09

Review 5.  The role of sympathectomy in long QT syndrome.

Authors:  Achilleas Antonopoulos; David Lawrence; Davide Patrini; Marco Scarci; Robert George; Martin Hayward; Sofoklis Mitsos; Nikolaos Panagiotopoulos
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

6.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

7.  Left thoracoscopic sympathectomy used as primary therapy for a young child with intractable long QT syndrome.

Authors:  Dingchao He; John P Costello; Evan P Nadler; Jeffrey P Moak; Richard A Jonas; Dilip S Nath
Journal:  Pediatr Cardiol       Date:  2012-09-26       Impact factor: 1.655

Review 8.  Cardiac Sympathetic Denervation for the Management of Ventricular Arrhythmias.

Authors:  Stephanie M Kochav; Hasan Garan; Lyall A Gorenstein; Elaine Y Wan; Hirad Yarmohammadi
Journal:  J Interv Card Electrophysiol       Date:  2022-04-09       Impact factor: 1.900

9.  Calming the storm by sympatholysis.

Authors:  Johnson Francis; Tara Bourke; Kalyanam Shivkumar
Journal:  Indian Pacing Electrophysiol J       Date:  2011-03-25

10.  Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes.

Authors:  L R A Olde Nordkamp; A H G Driessen; A Odero; N A Blom; D R Koolbergen; P J Schwartz; A A M Wilde
Journal:  Neth Heart J       Date:  2014-04       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.